Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer

Chiaki Omichi, Keiichiro Nakamura, Junko Haraga, Hisashi Masuyama, Yuji Hiramatsu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Inflammatory markers are important prognostic factors in various cancers. This study investigated whether inflammatory markers of the Glasgow prognostic score (GPS) predicted progression-free survival (PFS) and overall survival (OS) for patients with all cases of epithelial ovarian cancer (OC). Pretreatment GPS was examined for the correlations with PFS and OS in 216 patients in all stages of epithelial OC. Statistical analyses were performed using the Mann–Whitney U-test. PFS and OS were analyzed using the Kaplan–Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. For all patients, the median PFS was 35.1 months, and median OS was 46.7 months; follow-up range was 1–162 months. Kaplan–Meier analysis revealed that patients with high GPS (GPS 2) at pretreatment had a shorter PFS and OS than did patients with lower GPS (GPS 0 + 1) in for early, advanced, and all-stages of OC (PFS: P < 0.001 for early-, advanced- and all-stages; OS; P < 0.001 for early- and all-stage, P = 0.015 for advanced-stage). GPS (GPS 2) was also found to be an independent predictor of both recurrence (P = 0.002) and survival (P = 0.001) of all cases of epithelial OC by a multivariate analysis. GPS can serve as an indicator of poor prognosis in patients with all stages of epithelial OC, including early-stage disease and regardless of histology.

Original languageEnglish
Pages (from-to)1074-1080
Number of pages7
JournalCancer Medicine
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Disease-Free Survival
Survival
Multivariate Analysis
Ovarian epithelial cancer
Ovarian Neoplasms
Histology
Recurrence
Neoplasms

Keywords

  • Glasgow prognostic score
  • ovarian cancer
  • predictor for poor

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer. / Omichi, Chiaki; Nakamura, Keiichiro; Haraga, Junko; Masuyama, Hisashi; Hiramatsu, Yuji.

In: Cancer Medicine, Vol. 5, No. 6, 01.06.2016, p. 1074-1080.

Research output: Contribution to journalArticle

@article{5b63122994814f459206b0cae32bcf48,
title = "Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer",
abstract = "Inflammatory markers are important prognostic factors in various cancers. This study investigated whether inflammatory markers of the Glasgow prognostic score (GPS) predicted progression-free survival (PFS) and overall survival (OS) for patients with all cases of epithelial ovarian cancer (OC). Pretreatment GPS was examined for the correlations with PFS and OS in 216 patients in all stages of epithelial OC. Statistical analyses were performed using the Mann–Whitney U-test. PFS and OS were analyzed using the Kaplan–Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. For all patients, the median PFS was 35.1 months, and median OS was 46.7 months; follow-up range was 1–162 months. Kaplan–Meier analysis revealed that patients with high GPS (GPS 2) at pretreatment had a shorter PFS and OS than did patients with lower GPS (GPS 0 + 1) in for early, advanced, and all-stages of OC (PFS: P < 0.001 for early-, advanced- and all-stages; OS; P < 0.001 for early- and all-stage, P = 0.015 for advanced-stage). GPS (GPS 2) was also found to be an independent predictor of both recurrence (P = 0.002) and survival (P = 0.001) of all cases of epithelial OC by a multivariate analysis. GPS can serve as an indicator of poor prognosis in patients with all stages of epithelial OC, including early-stage disease and regardless of histology.",
keywords = "Glasgow prognostic score, ovarian cancer, predictor for poor",
author = "Chiaki Omichi and Keiichiro Nakamura and Junko Haraga and Hisashi Masuyama and Yuji Hiramatsu",
year = "2016",
month = "6",
day = "1",
doi = "10.1002/cam4.681",
language = "English",
volume = "5",
pages = "1074--1080",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer

AU - Omichi, Chiaki

AU - Nakamura, Keiichiro

AU - Haraga, Junko

AU - Masuyama, Hisashi

AU - Hiramatsu, Yuji

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Inflammatory markers are important prognostic factors in various cancers. This study investigated whether inflammatory markers of the Glasgow prognostic score (GPS) predicted progression-free survival (PFS) and overall survival (OS) for patients with all cases of epithelial ovarian cancer (OC). Pretreatment GPS was examined for the correlations with PFS and OS in 216 patients in all stages of epithelial OC. Statistical analyses were performed using the Mann–Whitney U-test. PFS and OS were analyzed using the Kaplan–Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. For all patients, the median PFS was 35.1 months, and median OS was 46.7 months; follow-up range was 1–162 months. Kaplan–Meier analysis revealed that patients with high GPS (GPS 2) at pretreatment had a shorter PFS and OS than did patients with lower GPS (GPS 0 + 1) in for early, advanced, and all-stages of OC (PFS: P < 0.001 for early-, advanced- and all-stages; OS; P < 0.001 for early- and all-stage, P = 0.015 for advanced-stage). GPS (GPS 2) was also found to be an independent predictor of both recurrence (P = 0.002) and survival (P = 0.001) of all cases of epithelial OC by a multivariate analysis. GPS can serve as an indicator of poor prognosis in patients with all stages of epithelial OC, including early-stage disease and regardless of histology.

AB - Inflammatory markers are important prognostic factors in various cancers. This study investigated whether inflammatory markers of the Glasgow prognostic score (GPS) predicted progression-free survival (PFS) and overall survival (OS) for patients with all cases of epithelial ovarian cancer (OC). Pretreatment GPS was examined for the correlations with PFS and OS in 216 patients in all stages of epithelial OC. Statistical analyses were performed using the Mann–Whitney U-test. PFS and OS were analyzed using the Kaplan–Meier method. Cox's proportional hazard regression was used for univariate and multivariate analyses. For all patients, the median PFS was 35.1 months, and median OS was 46.7 months; follow-up range was 1–162 months. Kaplan–Meier analysis revealed that patients with high GPS (GPS 2) at pretreatment had a shorter PFS and OS than did patients with lower GPS (GPS 0 + 1) in for early, advanced, and all-stages of OC (PFS: P < 0.001 for early-, advanced- and all-stages; OS; P < 0.001 for early- and all-stage, P = 0.015 for advanced-stage). GPS (GPS 2) was also found to be an independent predictor of both recurrence (P = 0.002) and survival (P = 0.001) of all cases of epithelial OC by a multivariate analysis. GPS can serve as an indicator of poor prognosis in patients with all stages of epithelial OC, including early-stage disease and regardless of histology.

KW - Glasgow prognostic score

KW - ovarian cancer

KW - predictor for poor

UR - http://www.scopus.com/inward/record.url?scp=85006215765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006215765&partnerID=8YFLogxK

U2 - 10.1002/cam4.681

DO - 10.1002/cam4.681

M3 - Article

C2 - 26929186

AN - SCOPUS:85006215765

VL - 5

SP - 1074

EP - 1080

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 6

ER -